Navigation Links
Questcor Pharmaceuticals Accelerates Cash Dividend; Payment Date Set for December 21, 2012
Date:12/4/2012

ANAHEIM, Calif., Dec. 4, 2012 /PRNewswire/ -- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share to all shareholders of record at the close of business on December 14, 2012.  The dividend will be paid in lieu of the Company's regular quarterly cash dividend that would have been paid in the first quarter of 2013, and is scheduled to be paid on or about December 21, 2012.  The Company accelerated payment of the first quarter 2013 dividend to allow its shareholders to benefit from the current dividend tax rate that is scheduled to expire on December 31, 2012.  Future dividends will be at the discretion of the Board of Directors.

"Our business continues to grow and this dividend reflects our positive outlook and confidence in our ability to continue to generate returns for shareholders and invest in future growth through R&D," said Don M. Bailey, President and CEO of Questcor.

About Questcor 

Questcor Pharmaceuticals, Inc. is a biopharmaceutical company focused on the treatment of patients with serious, difficult-to-treat autoimmune and inflammatory disorders.  Questcor's primary product is H.P. Acthar® Gel (repository corticotropin injection), an injectable drug that is approved by the FDA for the treatment of 19 indications.  Of these 19 indications, Questcor currently generates substantially all of its net sales from three indications: the treatment of proteinuria in idiopathic types of nephrotic syndrome, the treatment of acute exacerbations of multiple sclerosis in adults, and the treatment of infantile spasms in children under two years of age. With respect to nephrotic syndrome, the FDA has approved Acthar to "induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathi
'/>"/>

SOURCE Questcor Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Questcor Pharmaceuticals to Present at JMP Securities Healthcare Conference
2. Questcor to Report Second Quarter Results on July 24, 2012
3. Questcor Reports Second Quarter Financial Results
4. Questcor Pharmaceuticals to Present at Investor Conferences in September
5. Questcor and The Myositis Association Team Up To Support Research and Educational Initiatives in Polymyositis and Dermatomyositis
6. Questcor Comments on Insurance Policy Bulletin
7. Questcor to Conduct Conference Call to Discuss Reimbursement Process
8. Harwood Feffer LLP Announces Investigation of Questcor Pharmaceuticals, Inc.
9. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
10. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
11. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... , Sept. 16, 2014 ... of the "Global Laparoscopy Devices Industry Report ... The Global Laparoscopy Devices Industry Report 2014 ... current state of the global laparoscopic devices. ... the industry including definitions, classifications, applications and industry ...
(Date:9/16/2014)... 16, 2014 The National Association of ... simultaneously released the NAMCP Medical Technologies Dossier Template ... Template © , which provide medical directors and ... medical devices or diagnostics that accounts for evidence-based ... these technology types (instead of having to attempt ...
(Date:9/16/2014)... ORLANDO, Fla. , Sept. 16, 2014   ... standard in the patient experience at hospitals. The myComfort™ ... , Vestagen,s active barrier fabric that is fluid repellant, ... shown to inhibit the growth of bacteria on the ... the role clothing plays in the chain of transmission. ...
Breaking Medicine Technology:Global Laparoscopy Devices Industry Report 2014 2NAMCP Medical Directors Institute releases NAMCP Medical Technologies and Diagnostics Dossier Templates to provide model approach for medical devices or diagnostics 2New Vestagen Patient Garments Aim to Minimize Pathogen Transmission Inside Hospitals 2
... Med, the leading platform for automated revenue and charge ... the App Store for iPhone, iPod touch and iPad. ... company,s presence at the Hospital Information and Management Systems ... users to access the charge and data capture platform ...
... NexBio, Inc. announced the presentation of "Treatment of Parainfluenza ... Stem Cell Transplantation" at the American Society for Blood ... Honolulu, Hawaii.  The data was presented by Dr. Yi-Bin Chen, ... Medical School. Parainfluenza virus (PIV) infection causes ...
Cached Medicine Technology:HIMSS11: Ingenious Med Launches Billing and Data Capture App for iPhone, iPod touch and iPad 2NexBio’s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 2NexBio’s DAS181 (Fludase®*) Improved Symptoms in a Severely Immunocompromised Patient with Parainfluenza Pneumonitis 3
(Date:9/16/2014)... Kathleen Doheny HealthDay ... A simple urine test can routinely spot human papillomavirus (HPV), ... new analysis found. "Our study shows that testing urine ... taken from the cervix for HPV," said lead researcher Dr. ... and research fellow at Queen Mary University of London, England. ...
(Date:9/16/2014)... MN (PRWEB) September 16, 2014 Cliff Lake ... their team. Kristaleen is the newest dental hygienist to join ... looks forward to working with her and knows she will ... her patients. , Kristaleen grew up in River Falls, WI. ... County Technical College in 2003 and practiced dental assisting in ...
(Date:9/16/2014)... CO (PRWEB) September 16, 2014 Aspen ... that it has been recognized for its high morale ... Consulting magazine “The Best Small Firms to Work For ... survey annually, with more than 10,000 consultants participating across ... Extensive employee satisfaction surveys were conducted, and firms were ...
(Date:9/16/2014)... Treatment with endocrine therapy and radiation therapy as ... of care for women with hormone-receptor positive (HR+) ... at Fox Chase Cancer Center, however, shows that ... populations with the disease. , The results, ... Society for Radiation Oncology,s 56th Annual Meeting on ...
(Date:9/16/2014)... York, NY (PRWEB) September 16, 2014 ... children around the world will be honored in New ... Award ( http://www.worldofchildren.org ), the only global recognition and ... , Hailed by the media as the “Nobel ... individuals have each created life-changing programs that benefit children ...
Breaking Medicine News(10 mins):Health News:Urine Test for HPV Works Well, Analysis Finds 2Health News:Cliff Lake Dental Care Announces Newest Team Member 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 2Health News:Aspen Advisors Earns Recognition in Consulting Magazine’s "Best Small Firms to Work For" 3Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 2Health News:Benefit of endocrine therapy in elderly women with low risk hormone receptor positive breast cancer? 3Health News:World of Children® Award Announces 2014 Honorees 2Health News:World of Children® Award Announces 2014 Honorees 3Health News:World of Children® Award Announces 2014 Honorees 4Health News:World of Children® Award Announces 2014 Honorees 5Health News:World of Children® Award Announces 2014 Honorees 6Health News:World of Children® Award Announces 2014 Honorees 7Health News:World of Children® Award Announces 2014 Honorees 8
... inventor,of Pulse CO-Oximetry and Read-Through Motion and Low Perfusion ... at the Piper,Jaffray 19th Annual Healthcare Conference at The ... 2007 at 8:30 a.m. ET. Joe Kiani, Chairman and,CEO, ... will be,presenting. A live Web cast of the ...
... to 60%, study found , THURSDAY, Nov. 15 (HealthDay News) ... oils, fruits and vegetables may reduce the risk of dementia ... may boost the risk of developing memory problems, say French ... people older than 65 who did not have dementia at ...
... a 150 percent increase between 1998 and 2003 in ... cancer has been found in only one breasta procedure ... study to examine these trends on a national level. ... unnecessary since most patients will never develop cancer in ...
... Just and Stanford postdoctoral fellow Sashank Varma have put ... provides answers to one of the central questions of ... to give rise to complex cognitive tasks such as ... theory, called 4CAPS, is described in the fall issue ...
... Proceeds from the Mural will Benefit St. Jude Children,s Research ... Jude Thanks and Giving Campaign, Event to be ... at Bryant Park, NEW YORK, Nov. 15 Visitors ... become artists for a day, as they,help put the finishing ...
... ... Affordable Program Company Provides Upscale ... the leading meal,delivery service provider based on the Dr. Sears, Zone Diet ... that provides,chef-prepared, gourmet frozen meals for as low as $9.99 per day*. ...
Cached Medicine News:Health News:Masimo to Present at Piper Jaffray 19th Annual Healthcare Conference 2Health News:Fish, Fruits, Veggies May Cut Dementia Risk 2Health News:More women are choosing double mastectomy even when breast cancer is confined to a single breast 2Health News:Carnegie Mellon neuroscientist proposes new theory of brain flexibility 2Health News:Carnegie Mellon neuroscientist proposes new theory of brain flexibility 3Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 2Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 3Health News:American Airlines Invites the Public to Join Marlo Thomas and St. Jude Patients to Create One-of-a-Kind Mural to Celebrate 80 Years of Service in the Greater New York Area 4Health News:CHEFS DIET(R) Introduces My Solution 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: